WuXi AppTec plants ‘flag down’ in Europe with new Munich headquarters news2025-11-12T17:39:33+00:00November 12th, 2025|Endpoints News|
Why class competition hasn’t brought checkpoint inhibitor prices downnews2025-11-11T19:25:52+00:00November 11th, 2025|Endpoints News|
Top biopharma execs set to appear at MAHA Summitnews2025-11-11T19:12:13+00:00November 11th, 2025|Endpoints News|
CDMOs don’t expect immediate impact from ‘most favored nation’ dealsnews2025-11-11T16:04:01+00:00November 11th, 2025|Endpoints News|
KalVista defies sales expectations again for Ekterlynews2025-11-11T14:51:41+00:00November 11th, 2025|Endpoints News|
Jury gives Novo Nordisk a win in decade-long hemophilia fraud casenews2025-11-10T20:44:45+00:00November 10th, 2025|Endpoints News|
#AHA25: Ionis claims curative potential for Tryngolza in severe triglyceride diseasenews2025-11-10T12:03:22+00:00November 10th, 2025|Endpoints News|
#AASLD25: Vir presents new hepatitis D data and ramps up bullish Phase 3 plansnews2025-11-09T23:15:42+00:00November 9th, 2025|Endpoints News|
#AHA25: Merck reports pivotal PCSK9 pill data in race to beat AstraZeneca to marketnews2025-11-09T22:00:40+00:00November 9th, 2025|Endpoints News|
#AHA25: Amgen’s cholesterol drug cuts first-time cardiovascular events by a quarternews2025-11-08T15:10:59+00:00November 8th, 2025|Endpoints News|
